Summary

Revenue : 000,000 M USD
Finance : 000,000 M USD
Earning Cap : 000,000 M USD
Invest : 000,000 M USD
R & D : 0000 People
Growth : 00% AGR

DIGDAL CAP

Overview

General Introduction Northeast Pharmaceutical Group Co., Ltd. (referred to as "Northeast Pharmaceutical") is a listed company under Liaoning Fangda Group Industrial Co., Ltd. (referred to as "Fangda Group"). The company's predecessor was Northeast Pharmaceutical General Factory, founded in 1946. Listed on the Shenzhen Stock Exchange in 1996 with stock code 000597. Northeast Pharmaceutical is an important pharmaceutical production and export base in China, and one of the largest single agent production bases in China. It is also a production base for hemp essence drugs and anti AIDS drugs in China. It is a national demonstration factory for intelligent manufacturing of bulk raw materials and pharmaceutical intermediates, and has a national level enterprise technology center and innovative drug incubation base.
Headquarter Shenyang
Establish Date 6/10/1993
Listed Code 000597.SZ
Listed Date 5/23/1996
Chairman Guo Jianmin.
CEO Zhou Kai.
Website www.nepharm.com.cn

Buy Premium Now

$15/month billed now

View the full stack of insights immediately

Or 7 Days Free Charge for Trial

See feature available in the Trial and Premium

See our Solution and Servicetrial.solutionservice.trial

See our Uniquness and Value deliveringtrial.solutionservice.trial